Carl Quintanilla and Jim Cramer led off the show by delving into the broadening market rally, as the S&P 500 and Nasdaq aim for a ninth consecutive day of gains. David Faber called into the show with reporting on Edgar Bronfman's bid to acquire Paramount Global. Eli Lilly CEO David Ricks joined the program "First on CNBC" to discuss the pharma giant’s weigh ... Show More
Yesterday
11AM Hour: Goldman Sachs Chief U.S. Equity Strategist, Midterm Elections Impact on the Market & Micron to $3,000? 10/8/26
Goldman Sachs Chief U.S. Equity Strategist Ben Snider joins with his outlook for the market and where to invest right now. Then, Morgan Stanley Strategist Ariana Salvatore discusses how the midterm elections could impact the market. Plus, D.A. Davidson Analyst Gil Luria shares wh ... Show More
43m 36s
Yesterday
10AM Hour: Pepsi CEO on Earnings, High-Rate Playbook for Banks, Skydance CEOs on Financial Outlook & Content Strategy 10/8/26
PepsiCo CEO Ramon Laguarta joins Squawk on the Street to break down the company's latest earnings and outlook for consumer demand. Plus, KBW CEO Tom Michaud discusses how multi-decade highs in bond yields are impacting banks and the broader market. And in an exclusive interview, ... Show More
43m 47s
Sep 2020
Eli Lilly CEO, Coca Cola CEO & Albertsons CEO
<p>The Dow was down 942 points at its session lows in a September-style selloff to start the week and Jim Cramer is helping investors navigate the day’s volatility. Then, as pharmaceutical companies focus on COVID-19, Eli Lilly CEO Dave Ricks checks in to discuss the company's pr ... Show More
46m 19s
Jun 2022
Goodyear CEO, David Faber & Souring On Sweetgreen? 06/21/22
The Dow surged over 600 points, with the S&P and Nasdaq also rising, and Jim Cramer is bringing you up to speed on the market action that drove the indices higher. First, Goodyear CEO Richard Kramer joins CNBC's Cramer to talk about the company's latest innovations, supply chain ... Show More
44m 5s
Sep 2025
Novo Dips, AB Foods Slumps, Inditex Climbs
On this episode of Stock Movers: - Novo Nordisk will slash 9,000 jobs globally and cut its profit forecast for the third time this year as it fights to recover ground lost to its more efficient rival Eli Lilly & Co. in the booming obesity drug market. - Associated British Foods s ... Show More
4m 6s